Skip to content
Penwise

Muscle loss on a GLP-1, and what to do about it

Weight loss is not fat loss. Every method of losing weight, from a diet to bariatric surgery to a GLP-1, removes a mixture of fat and lean tissue, and the ratio is not fixed. It responds to what you eat and what you ask your body to do. On these drugs the ratio is a real question, because the appetite suppression that makes the loss easy also makes it easy to eat far too little protein without noticing.

Updated 24 August 2026 · Written by the Penwise team

What the body composition data shows

The imaging substudies of the major trials found that lean mass accounts for a meaningful share of the weight lost, broadly in line with what other forms of substantial calorie restriction produce. Figures around a quarter to a third of total weight lost are commonly cited, with wide individual variation.

Two things are worth separating here, because they get argued about as though they were one.

Why it matters more later than now

In the first six months almost nobody notices. The problems show up further out.

Function and strength

Muscle is what carries shopping, climbs stairs and prevents falls later in life. Losing a lot of it while losing weight trades one health problem for a slower one.

Resting energy expenditure

Lean tissue is metabolically active. Less of it means a lower daily burn, which makes maintaining the loss harder than it needed to be.

What regain is made of

Weight regained after stopping tends to be predominantly fat. Losing lean mass and regaining fat leaves a worse composition at the same body weight, which is the strongest practical argument for getting this right on the way down. See what happens when you stop.

The scale cannot see any of it

Two people down fifteen kilograms can be in materially different positions, and the number on the scale is identical. This is the single best reason to track something besides weight.

The protein problem these drugs create

This is the specific mechanism, and it is worth being precise about it. GLP-1 drugs reduce total intake. Protein is usually the part of a meal that gets dropped first, because it is the most filling per bite and because meat in particular becomes less appealing for many people on treatment. So the macronutrient you most need to protect is the one appetite suppression removes first.

Commonly cited targets for someone losing weight sit around 1.2 to 1.6 grams of protein per kilogram of body weight per day, with higher figures suggested for older adults. Your prescriber or a dietitian should set your number, particularly if you have kidney disease, where protein intake is a clinical decision rather than a general recommendation.

What people find works in practice, given a much smaller appetite:

  1. Protein first at every meal. Eat it before anything else on the plate, because you will reach fullness before the plate is empty.
  2. Spread it across the day rather than relying on one large evening meal that you may no longer be able to finish.
  3. Liquid protein when solid food is unappealing. In the days after a shot, when nausea is highest, a shake often gets down when a chicken breast will not.
  4. Do not let a bad week become a bad month. A few low days after a dose increase are normal. Six weeks of very low protein is the thing that shows up in body composition.

The days after your shot are the hardest here, which is another reason the injection day placement matters, and the gut effects page covers eating when nausea is in the way.

Resistance training is the other half

Protein supplies the material. Resistance training supplies the signal that the material should go into muscle rather than being skipped over. Neither works nearly as well without the other, and this is the more reliable of the two findings in the wider weight loss literature.

The dose that matters is smaller than people assume. Two or three sessions a week covering the major movement patterns, taken close enough to hard that the last repetitions are difficult, is the intervention. It does not require a gym, an hour a day or any particular programme, and walking, while excellent for other reasons, does not substitute for it.

Expect the scale to under-report your progress if you do this, particularly early on. That is the point rather than a problem: the composition of the loss is better even when the number moves more slowly.

How to actually see it

None of this is visible on a bathroom scale that reports one number. Four things that are worth tracking, in rough order of usefulness:

Penwise records weight, body composition and measurements together, so the trend you look at is composition alongside mass rather than mass alone, and it reads body composition from Apple Health or Health Connect if your scale writes there. The weight loss timeline covers what the overall curve normally looks like, and the plateau page covers reading a flat scale that is still hiding progress.

What not to conclude from this

Two overcorrections are worth naming, because both do harm.

The first is treating lean mass loss as a reason not to treat obesity. The health consequences of the weight being carried are the thing being addressed, and they are large. The trials that measured body composition also measured cardiovascular and metabolic outcomes, and those improved.

The second is protein intakes far above the recommended range on the assumption that more must be better. There is no evidence of benefit past the ranges above for this purpose, it displaces other food from an already small intake, and at high levels it is a genuine clinical question for anyone with reduced kidney function.

Track the composition, not just the number

Weight, body composition and measurements in one trend, synced from Apple Health or Health Connect. Free core tracker, no account.

Common questions

How much muscle do you lose on a GLP-1?
Body composition substudies of the major trials found lean mass accounting for a meaningful share of the weight lost, with figures around a quarter to a third commonly cited and wide individual variation. That is broadly in line with other forms of substantial calorie restriction rather than unique to these drugs.
How much protein should I eat on Mounjaro or Wegovy?
Commonly cited targets for someone losing weight are around 1.2 to 1.6 grams per kilogram of body weight per day, with higher figures suggested for older adults. Your prescriber or a dietitian should set your number, particularly if you have any degree of kidney disease.
Does weight training prevent muscle loss while on a GLP-1?
It substantially changes the ratio of fat to lean mass in what you lose, and it works best combined with adequate protein. Two or three resistance sessions a week covering the major movement patterns is the intervention; walking is valuable for other reasons but does not replace it.
Why is it so hard to eat enough protein on these drugs?
Appetite suppression reduces total intake, and protein is usually what gets dropped first because it is the most filling per bite and because meat often becomes less appealing during treatment. Eating protein first at each meal and using liquid protein in the days after a shot are the two things that most reliably help.
Will I regain muscle if I stop?
Weight regained after stopping tends to be predominantly fat rather than lean mass, which is why the composition of the loss on the way down matters. Regaining muscle specifically requires resistance training and adequate protein, the same as building it in the first place.
Are bioimpedance scales accurate enough to track this?
Their absolute numbers should not be taken literally, since hydration alone moves them. Measured under consistent conditions, the trend is still informative, and combining it with waist measurements and with what your working weights are doing gives a far better picture than the scale alone.

Sources

Every factual claim on this page traces to the product information a regulator publishes, or to a published trial. Links open on the site of whoever issued the document.

  1. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) New England Journal of Medicine, 2022
  2. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) New England Journal of Medicine, 2021
  3. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4) JAMA, 2024

Penwise is a tracking and education tool, not a medical device. Nothing on this page is medical advice, a diagnosis or a recommendation to start, stop or change a dose. Dosing decisions belong to you and your clinician. Ozempic, Wegovy, Rybelsus, Saxenda and Victoza are trademarks of Novo Nordisk; Mounjaro, Zepbound and Trulicity are trademarks of Eli Lilly. Penwise is not affiliated with, endorsed by or connected to either company.

Occasional updates, nothing else.

New features, what we are working on, and the odd thing we learn about GLP-1 tracking. A few times a year at most.

We only use your address for this newsletter. Unsubscribe from any email. Your health data is never involved: it stays on your phone.